-
-
-
-
-
-
-
Quince acquires Orphai for LAM-001 drug, raises up to $187 million
-
-
-
-
-
-
-
Quince Therapeutics (QNCX) Appoints Rajiv Patni to its Board
-
-
-
-
-
-
-
Quince Therapeutics (QNCX) to Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia
-
-
-
-
-
-
-
Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor
-
-
-
-
-
-
-
Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
-
-
-
-
1,168,812 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

